Endothelium and venotropic drugs in chronic venous insufficiency: A review

Phlebology

Volumn 17, Issue 3-4, 2002, Pages 145-150

  Michiels, Carine ^a   Remacle, J ^a   Bouaziz, N ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Endothelial cells; Hypoxia; Mitochondrial respiratory activity; Neutrophils; Varicose veins; Venotopic drugs

Indexed keywords

DAFLON; ESCIN; GINKGO BILOBA EXTRACT; GINKOR FORT; MELILOTUS EXTRACT; MONOXERUTIN; NAFTAZONE; NAFTIDROFURYL OXALATE; PROCYANIDOL OLIGOMER; RUSCUS ACULEATUS EXTRACT; RUTOSIDE; VASOACTIVE AGENT;

BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CHRONIC VEIN INSUFFICIENCY; DRUG MECHANISM; HUMAN; HYPOXIA; INFLAMMATION; LEG VEIN; MITOCHONDRIAL RESPIRATION; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; VARICOSIS; VASCULAR ENDOTHELIUM; VEIN TONE;

EID: 0036966156     PISSN: 02683555     EISSN: None     Source Type: Journal    
DOI: 10.1177/026835550201700314     Document Type: Review

References (52)

1. Hume M. Venous ulcers, the vascular surgeon, and the Medicare budget. J Vasc Surg 1992;16:671-3.
2. Michiels C, Arnould T, Bouaziz N, Thibaut-Vercruyssen R, Remacle J. Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia. Int Angiol 1997;16:134-41.
3. Badier-Commander C, Couvelard A, Henin D, Verbeuren T, Michel JB, Jacob MP. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 2001;193:398-407.
4. Rose SS, Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg 1986;27:534-43.
5. Travers JP, Brookes CE, Evans J, Baker DM, Kent C, Makin GS, Mayhew TM. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996;11:230-7.
6. Porto LC, da Silveira PR, de Carvalho JJ, Panico MD. Connective tissue accumulation in the muscle layer in normal and varicose saphenous veins. Angiology 1995;46:243-9.
7. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare RJ, Tilson MD. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993;18:814-20.
8. Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002;106:479-83.
9. Porto LC, Azizi MA, Pelajo-Machado M, Matos da SP, Lenzi HL. Elastic fibers in saphenous varicose veins. Angiology 2002;53:131-40.
10. Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol 2000;192:105-12.
11. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:420-5.
12. Harrison DG. Endothelial dysfunction in atherosclerosis. Basic Res Cardiol 1994;89:87-102.
13. Toborek M, Kaiser S. Endothelial cell functions. Relationship to atherogenesis. Basic Res Cardiol 1999;94:295-314.
14. Gimbrone MA. Endothelial dysfunction, hemodynamic forces, and atherosclerosis. Thromb Haemost 1999;82:722-6.
15. Nayler WG. Atherosclerosis and endothelial damage: a brief overview. Cardiovasc Drugs Ther 1995;9:25-30.
16. Keaney JF. Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction. Mol Aspects Med 2000;21:99-166.
17. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001;104:503-16.
18. Smith PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology 2001;52(Suppl 1):S35-42.
19. Takase S, Schmid-Schonbein G, Bergan JJ. Leukocyte activation in patients with venous insufficiency. J Vasc Surg 1999;30:148-56.
20. Junger M, Steins A, Hahn M, Hafner HM. Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirculation 2000;7:S3-12.
21. Shields DA, Andaz SK, Sarin S, Scurr JH, Coleridge Smith PD. Plasma elastase in venous disease. Br J Surg 1994;81:1496-9.
22. Saharay M, Shields DA, Porter JB, Scurr JH, Coleridge Smith PD. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 1997;26:265-73.
23. Jacob MP, Cazaubon M, Scemama A, Prie D, Blanchet F, Guillin MC, Michel JB. Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation 2002;106:535-8.
24. Saharay M, Shields DA, Georgiannos SN, Porter JB, Scurr JH, Coleridge Smith PD. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 1998;15:342-9.
25. Korthuis RJ, Unthank JL. Experimental models to investigate inflammatory processes in chronic venous insufficiency. Microcirculation 2000;7:S13-22.
26. Saito S, Trovato MJ, You R, Lal BK, Fasehun F, Padberg T, et al. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg 2001;34:930-8.
27. Michiels C, Arnould T, Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 2000;1497:1-10.
28. Michiels C, Bouaziz N, Remacle J. Role of the endothelium and blood stasis in the appearance of varicose veins. Int Angiol 2002;21:1-8.
29. Arnould T, Michiels C, Alexandre I, Remacle J. Effect of hypoxia upon intracellular calcium concentration of human endothelial cells. J Cell Physiol 1992;152:215-21.
30. Michiels C, Renard P, Bouaziz N, Heck N, Eliaers F, Ninane N, et al. Identification of the phospholipase A2 isoforms that contribute to arachidonic acid release in hypoxic endothelial cells: limits of phospholipase A2 inhibitors. Biochem Pharmacol 2002;63:321-32.
31. Michiels C, Arnould T, Knott I, Dieu M, Remacle J. Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am J Physiol 1993;264:C866-74.
32. Arnould T, Michiels C, Remacle J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol 1993;264:C1102-10.
33. Michiels C, Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Janssens D, Remacle J. Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia. Int Angiol 1997;16:134-41.
34. Alguire PC, Mathes BM. Chronic venous insufficiency and venous ulceration. J Gen Intern Med 1997;12:374-83.
35. Mollard JM. Explorations fonctionnelles veineuses. Presse Med 1994;23:237-42.
36. Frick RW. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon. Angiology 2000;51:197-205.
37. Chauveau M. Traitements médicamenteux de l'insuffisance veineuse chronique: évaluation pharmaco-clinique. Presse Med 1994;23:243-9.
38. Neumann HA, Carlsson K, Brom GH. Uptake and localisation of O-(beta-hydroxyethyl)-rutosides in the venous wall, measured by laser scanning microscopy. Eur J Clin Pharmacol 1992;43:423-6.
39. Yoshikawa T, Naito Y, Kondo M. Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal 1999;1:469-80.
40. DeFeudis FV. Ginkgo biloba extract (EGb761). Wiesbaden: Ullstein Medical, 1998.
41. Liebgott T, Miollan M, Berchadsky Y, Drieu K, Culcasi M, Pietri S. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic Res Cardiol 2000;95:368-77.
42. Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res 2001;44:183-93.
43. Arnould T, Michiels C, Janssens D, Berna N, Remacle J. Effect of Ginkor Fort on hypoxia-induced neutrophil adherence to human saphenous vein endothelium. J Cardiovasc Pharmacol 1998;31:456-63.
44. Bougelet C, Roland IH, Ninane N, Arnould T, Remacle J, Michiels C. Effect of aescine on hypoxia-induced neutrophil adherence to umbilical vein endothelium. Eur J Pharmacol 1998;345:89-95.
45. Roland IH, Bougelet C, Ninane N, Arnould T, Michiels C, Remacle J. Effect of hydroxyethylrutosides on hypoxial-induced neutrophil adherence to umbilical vein endothelium. Cardiovasc Drugs Ther 1998;12:375-81.
46. Arnould T, Janssens D, Michiels C, Remacle J. Effect of aescine on hypoxia-induced activation of human endothelial cells. Eur J Pharmacol 1996;315:227-33.
47. Janssens D, Michiels C, Arnould T, Remacle J. Effects of hydroxyethylrutosides on hypoxia-induced activation of human endothelial cells in vitro. Br J Pharmacol 1996;118:599-604.
48. Bouaziz N, Michiels C, Janssens D, Berna N, Eliaers F, Panconi E, et al. Effect of Ruscus extract and hesperidin methylchalcone on hypoxia-induced activation of endothelial cells. Int Angiol 1999;18:306-12.
49. Michiels C, Arnould T, Janssens D, Alexandre I, Houbion A, Remacle J. Effects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells. J Pharmacol Exp Ther 1993;267:904-11.
50. Janssens D, Delaive E, Houbion A, Eliaers F, Remacle J, Michiels C. Effect of venotropic drugs on the respiratory activity of isolated mitochondria and in endothelial cells. Br J Pharmacol 2000;130:1513-24.
51. Michiels C, De Leener F, Arnould T, Dieu M, Remacle J. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF. Exp Cell Res 1994;213:43-54.
52. Bouaziz N, Redon M, Quere L, Remacle J, Michiels C. Mitochondrial respiratory chain as a new target for anti-ischemic molecules. Eur J Pharmacol 2002;441:35-45.